-
Representing Alibaba Group, Ant Financial, Ali Health, Cainiao, Ele.me in their investments in target companies covering a wide range of industry sectors including TMT, healthcare, entertainment, advertising, transportation and logistics.
-
Advising Morgan Stanley Private Equity Asia in its acquisition of a public hospital in Jiangsu Province and providing legal services in the daily operation and subsequent sale of controlling equity interests to CR Medical (01515.HK).
-
Representing Lumentum Holdings Inc. (NASDAQ:LITE) and providing PRC legal service in connection with its US$918m acquisition of NeoPhotonics Corporation (NYSE:NPTN).
-
Representing Blue Sail Medical (002382.SZ) in its RMB5.9bn acquisition of Biosensors International Group, one of the largest manufacturers and suppliers of cardiovascular stents globally.
-
Representing Hopu Investment in its 1) Series E investment in a leading fresh grocery delivery company; 2) exit from a US-listed electric vehicle manufacturer through Rule 144; 3) Series D investment in a major road transportation company.
-
Representing Ping'an Trust in its acquisition of a high-end medical clinic in Shenzhen.
-
Representing Taikang Life 1) in its Series B and Series B+ investment in Just Biotherapeutics; 2) in the merger between Just Biotherapeutics and MabSpace at Cayman level; 3) in its investment in a medical information system developing company.
